Takuya Ogura
Toranomon, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Combined use of immunoreactivities of Efp and ZCCHC3 for predicting prognosis of patients with triple-negative breast cancer.
Journal: Pathology international
Published: October 11, 2024
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: April 21, 2024
Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
Journal: Japanese journal of clinical oncology
Published: February 20, 2023
High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging.
Journal: Breast cancer (Tokyo, Japan)
Published: January 22, 2023
Solitary fibrous tumor of male breast: A case report and literature review.
Journal: Medicine
Published: December 23, 2022
OCT1 Is a Poor Prognostic Factor for Breast Cancer Patients and Promotes Cell Proliferation via Inducing NCAPH.
Journal: International journal of molecular sciences
Published: September 25, 2021
TRIM39 is a poor prognostic factor for patients with estrogen receptor-positive breast cancer and promotes cell cycle progression.
Journal: Pathology international
Published: September 12, 2021
Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.
Journal: Pathology international
Published: October 06, 2020
Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
Journal: Clinical breast cancer
Published: July 15, 2020
Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 08, 2019
Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
Journal: Breast cancer (Tokyo, Japan)
Published: October 11, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026